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Abstract: West Nile virus (WNV) threatens the health of humans and equines worldwide. Culex 
(Cx.) pipiens complex mosquitoes are major vectors but numerous other species have been 
implicated. Due to variations in blood-feeding behaviour, Cx. pipiens biotypes and hybrids influence 
transmission, from enzootic cycles (between mosquitoes and birds), to spill-over transmission to 
humans and equines. In this study, mosquitoes were collected in May–June 2018 during the early 
period of the transmission season from two regional units of Greece, where WNV cases had been 
reported in the previous four years (Palaio Faliro and Argolida). A total of 1062 mosquitoes were 
collected with Biogents Sentinel 2 traps collecting both a greater number of all mosquito species and 
the Cx. pipiens complex than CDC miniature light traps or Heavy Duty EVS traps. Molecular 
identification confirmed additional species including Aedes albopictus. The proportion of Cx. pipiens 
biotypes in Palaio Faliro was 54.5% pipiens, 20.0% molestus and 25.5% hybrids. In Argolida, the 
collection comprised 68.1% pipiens biotype, 8.3% molestus biotype and 23.6% hybrids. Screening 
resulted in WNV detection in three females of the pipiens biotype and in one hybrid. As hybrids play 
a role in spill-over transmission, these findings highlight the importance of entomological 
surveillance programs incorporating molecular xenomonitoring as an early warning before human 
cases at the onset of the transmission season. 
Keywords: mosquitoes; West Nile virus; Culex pipiens complex; molecular xenomonitoring 
 
1. Introduction 
West Nile virus (WNV) is an arbovirus belonging to the Japanese encephalitis serocomplex 
within the Flavivirus genus (Flaviviridae family) and is the most widespread flavivirus, with 
circulation worldwide, including the USA and Europe [1–4]. Natural transmission of WNV mainly 
occurs in enzootic cycles between birds and competent ornithophilic mosquito vectors, with avian 
species being the principal maintenance and amplifying hosts of WNV as many species develop 
sufficient viremia for onward transmission [5–7]. Enzootic transmission can continue onward where 
infected mosquitoes are present in a specific area under suitable environmental conditions [8]. 
Additionally, spill-over transmission can occur when competent vectors feed on humans or horses. 
During natural transmission both humans and horses are considered dead-end hosts since they 
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cannot sustain sufficient viraemia for further vector-borne transmission [9]. However, infection in 
humans does pose a transmission risk due to the possibility of iatrogenic transmission through blood 
and tissue donations, in addition to the possibility of intrauterine transmission or WNV being passed 
on through breast milk [4]. Blood and tissue donor screening is essential in areas where WNV is 
endemic [10,11]. Although currently no human vaccination is available, vaccination of horses has 
been shown to reduce clinical disease within this species [12,13]. 
WNV was first isolated in 1937 from a woman with febrile illness in the West Nile district of 
Uganda [14]. WNV has caused numerous annual outbreaks in North America and Europe leading to 
major concern for human and animal health [3,15]. In North America, the majority of arboviral 
encephalitis cases are attributable to WNV [16]. Although ~80% of human WNV infections are 
asymptomatic, the broad clinical spectrum can result ranging from a mild flu-like illness in ~20% of 
infected individuals (West Nile fever) to severe neurological disease through infection of the central 
nervous system (<1% of infected individuals) that can lead to death from meningitis, encephalitis and 
acute flaccid paralysis [17,18]. Therefore, a high proportion of asymptomatic infections highlights 
that the number of human cases demonstrating overt disease, or discovered through laboratory 
testing, are likely just the ‘tip of the iceberg’ of the actual number of viral infections occurring within 
a population [19]. Furthermore, these spill-over infections in humans are likely to be far less frequent 
compared to the amount of enzootic transmission occurring between mosquitoes and avian species 
[20]. 
The introduction and spread of WNV in Europe is thought to have been driven by migratory 
birds [21–24]. WNV resulted in sporadic human cases from the mid-1990s [25] but was considered to 
be an increasing public health concern with the first large outbreak in Europe occurring in Romania 
in 1996 with 393 hospitalised cases and 17 deaths [26]. From 2010, the European Centre for Disease 
Control (ECDC) have monitored WNV cases in the European Union and neighbouring countries and 
publishes weekly epidemiological reports [27]. In Greece, WNV was first detected in the summer of 
2010 in the central Macedonia Region near the city of Thessaloniki, in the northern part of the country 
[28,29]. This outbreak included 262 probable and confirmed cases of WNV infection of which 197 
were neuroinvasive cases and 35 deaths [30]. In 2011 WNV was found in both humans and horses; 
detected from clinical and laboratory surveillance techniques [31]. In the following years, cases of 
WNV in humans and animals were reported in central Greece and in the Attica Region but there were 
no reported cases in 2015 or 2016 [31]. In 2017, WNV re-emerged in southern Greece and in 2018 there 
were 311 laboratory confirmed human cases, resulting in 47 deaths, showing a marked increase over 
2017, with only 48 confirmed cases and 5 deaths [27,31]. Historical data of human cases with 
neurological disease in Greece from 2010 until present show that cases increase in August (the peak 
month in the transmission season) and prior to 2018, the largest case numbers per month were 
reported in August 2010 [30–32]. There have been over 60 species of mosquitoes in the USA 
implicated as potential WNV vector species [4]. Seven of these species occur in Europe and have been 
tested for WNV susceptibility using laboratory vector competence experiments including members 
of the Cx. pipiens complex, Ae. albopictus and Ae. (Ochlerotatus) caspius [33]. WNV transmission rates 
of European Cx. pipiens complex mosquitoes ranged between 0%–60%, 40%–55% for Cx. modestus, 
0%–40% for Ae. albopictus and 0%–1% for Ae. caspius (reviewed in [33]). Temperature has been shown 
experimentally to increase WNV transmission rates of the pipiens and molestus biotypes, in addition 
to the sibling species Cx. torrentium [34]. According to the ECDC, the most important vector species 
for the transmission of WNV to humans present in Europe are Cx. pipiens s.l. and Cx. modestus [35]. 
This year, horizontal and vertical transmission of WNV by Ae. vexans was also confirmed [36]. 
The Culex pipiens complex consists of morphologically indistinguishable species including Cx. 
pipiens, Cx. quinquefasciatus, Cx. pallens and Cx. australicus that have varied behaviour, physiology and 
host preference [37,38]. Within Europe, Cx. torrentium is also often morphologically indistinguishable 
from species in the Cx. pipiens complex [39]. Culex pipiens has two behaviourally different biotypes, 
pipiens and molestus, which can form hybrids, and their feeding behaviours can influence their role in 
local transmission of WNV. The two biotypes are morphologically indistinguishable but have genetic, 
biological and behavioural differences. The pipiens biotype is anautogenous, so females need to 
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consume a blood meal to lay eggs [40]. Furthermore, the pipiens biotype requires a large space to 
swarm for mating and are found above ground undergoing diapause. Although the pipiens biotype 
is considered an important species for the enzootic WNV transmission cycle given its preference to 
feed on birds [41,42], other studies have shown diverse host-feeding patterns including the 
occurrence of human derived blood meals in addition to mixed avian-human blood meals [43]. In 
contrast, the molestus biotype is autogenous and can lay eggs without a blood meal. Mating can 
happen in confined spaces, while they live underground, do not undergo diapause and are more 
anthropophilic, preferentially feeding on humans. The molestus biotype and hybrids are implicated 
in the spill-over transmission of WNV from avian hosts to humans due to the opportunistic feeding 
behaviour of the molestus biotype [42,43]. In Greece, hybrids have previously been detected [44] in 
addition hybrids of pipiens and quinquefasciatus on the Kos Island [45]. 
In order to better understand the complexity of WNV transmission, entomological surveys for 
arboviral surveillance can be undertaken to determine both the presence of potential mosquito 
vectors and provide evidence for WNV circulation through virus detection in field-caught 
mosquitoes (molecular xenomonitoring). Entomological surveillance could provide an important role 
in the monitoring and prevention of major outbreaks. Here we report the results of an entomological 
survey undertaken at pre-disease stage (no autochthonous cases detected in animals or humans) in 
two Regional Units (RUs) of Greece (Palaio Faliro in the Attica region and Argolida in the 
Peloponnese region) where WNV outbreaks have previously been recorded. We compared the 
mosquito species abundance and diversity using Biogent sentinel 2 (BG) traps, Heavy duty 
Encephalitis Vector Survey (EVS) traps and Centre for Disease Control miniature light (CDC) traps. 
We determined the prevalence of the Cx. pipiens biotypes (pipiens, molestus and hybrids) in each 
sampling location and female mosquitoes were screened for the presence of WNV to determine 
whether there was any evidence of virus circulation in the two RUs. 
2. Materials and Methods 
2.1. Mosquito Collections 
The study was carried out in two Regional Units (RUs) within the Attica and Peloponnese 
regions of Greece, with three sampling locations selected from within each RU, and three trapping 
sites within each sampling location (Figure 1, Table S1). Locations for trapping in the RU of Palaio 
Faliro were classified as urban, whereas those in the RU of Argolida were rural. In each sampling 
location, three different traps (trapping sites) were operating for 24 h, three times per week on 
consecutive days. Trapping occurred over a six-week period (May–June 2018) during the start of the 
WNV transmission season (based on previous historical data obtained from ECDC [27]). Traps were 
setup on fully charged 12 V batteries at 14:00 and run until 09:00 the following day to provide 
overnight collections. A 3 × 3 design was applied at each site to minimize site and environmental 
confounding factors and traps were placed more than 100 m from each other and rotated every 24 h 
between selected positions so that each trap had been used in every site. Three different trap types 
were used in each site to maximise the diversity of species collected; BG2 traps (Biogents, 
Regensburg, Germany), Heavy Duty Encephalitis Vector Survey trap (EVS trap) (BioQuip Products, 
Rancho Dominguez, California, USA) and CDC traps (John W. Hock, Gainesville, Florida, USA). Dry 
ice was used as an attractant in all traps with approximately 2 kg/rap per 24 h. All traps were run for 
six consecutive weeks (four in Palaio Faliro followed by two in Argolida). Mosquitoes were collected 
every 24 h, killed on dry ice and stored at −80 °C. Morphological keys were used to identify 
individuals to species or species complex level [46] 8–10 days after collection using a large (100 mm 
× 20 mm) polysterene petri dish sat on a 1:1 mixture of ice and acetone. Female mosquitoes were 
classified as unfed (no evidence of blood in their abdomen), blood-fed or gravid. Individual 
mosquitoes were then placed in RNAlater (Invitrogen) to preserve RNA for downstream molecular 
analysis. 
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Figure 1. (A) Locations of collection sites within the Regional Unit of Argolida in the Peloponnese 
region and within the Regional Unit of Palaio Faliro in Attica the region; (B) sampling locations with 
the trapping sites within Argolida and (C) Palaio Faliro. Maps constructed in ArcMap 10.5 (Esri, 
ArcGIS), using World Topographic Basemap and GPS coordinates from trapping sites. 
2.2. DNA/RNA Extraction and cDNA Synthesis 
DNA was extracted from individual male mosquitoes using QIAGEN DNeasy Blood and Tissue 
Kits (Qiagen, Manchester, UK) according to manufacturer’s instructions as WNV virus screening was 
not undertaken on males. DNA extracts were eluted in a final volume of 100 μL and stored at −20 °C. 
RNA was extracted from individual female mosquitoes using Roche High Pure RNA Isolation Kits 
(Roche Diagnostics, Mannheim, Germany) and QIAGEN RNeasy 96 kits (Qiagen, Manchester, UK) 
according to manufacturer’s instructions. RNA extracts were eluted in a final volume of 45 μL and 
stored at −80 °C. RNA was reverse transcribed into complementary DNA (cDNA) using an Applied 
Biosystems High Capacity cDNA Reverse Transcription kit (USA). A final volume of 20 μL contained 
10 μL RNA, 2 μL 10x RT buffer, 0.8 μL 25x dNTPs (100 mM), 2 μL 10x random primers, 1μL reverse 
transcriptase and 4.2 μL nuclease-free water. Reverse transcription was undertaken in a Bio-Rad T100 
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Thermal Cycler as follows: 25 ºC for 10 min, 37 ºC for 120 min and 85 ºC for 5 min, with the cDNA 
stored at −20 °C. 
2.3. Molecular Identification of Species 
Species previously shown to be potential WNV vectors were first identified through Sanger 
sequencing of conserved cytochrome c oxidase 1 (CO1) gene fragments [47–49]. As in previous 
studies looking at diverse mosquito species, amplifying and sequencing different CO1 regions was 
required for confirmation of different species. Specimens identified as within the Cx. pipiens complex 
were further identified to species level using a combination of multiplex species-specific PCR assays 
given the inability to discriminate species through sequencing CO1 regions [37,50]. PCR products 
were separated and visualized using 2% E-gel EX agarose gels (Invitrogen) with SYBR safe and an 
Invitrogen E-gel iBase Real-Time Transilluminator. PCR products were submitted to Source 
BioScience (Source BioScience Plc, Nottingham, UK) for PCR reaction clean-up, followed by Sanger 
sequencing to generate both forward and reverse reads. Sequencing analysis was carried out in 
MEGA7 [51] as follows. Both chromatograms (forward and reverse traces) from each sample was 
manually checked, analysed and edited as required, followed by alignment by ClustalW and 
checking to produce consensus sequences. Consensus sequences were used to perform nucleotide 
BLAST (NCBI) database queries and sequences were compared to those available from GenBank 
(NCBI). Representative full consensus sequences for CO1 gene fragments were submitted to GenBank 
and assigned accession numbers MN005042-MN005056. 
2.4. WNV Screening 
Screening for WNV detection was undertaken on cDNA resulting from individual female 
mosquito RNA extracts using a WNV-specific real-time PCR assay [52]. Reactions were prepared 
using 5 μL of Qiagen QuantiTect SYBR® Green Master mix, a final concentration of 1 μM of each 
primer, 1 μL of PCR grade water and 2 μL template cDNA, to a final reaction volume of 10 μL. 
Prepared reactions were run on a Roche LightCycler® 96 System and PCR cycling conditions were as 
follows: 95 °C for 10 min followed by 45 cycles of 95 °C for 10 s, 60 °C for 10 s, 72 °C for 20 s. PCR 
products were also separated and visualised using 2% E-Gel EX agarose gels (Invitrogen) with SYBR 
safe and an Invitrogen E-Gel iBase Real-Time Transilluminator to confirm successful amplification of 
the 144 base pair target fragment. 
2.5. WNV Case Mapping 
Human WNV reported cases were mapped for the year of collection to provide context to the 
entomological survey. Maps were constructed in ArcMap 10.5 (ArcGIS, Esri, Redlands, USA) using 
Global Administrative layers for Greece (level 3), downloaded from www.gadm.org (Version 3.6) 
and anonymized ECDC WNV case report data from “Transmission of West Nile virus, June to 
December 2018 – Table of cases, 2018 transmission season” downloaded from www.ecdc.europa.eu. 
The EU NUTS (Nomenclature of territorial units for statistics) level 3 regions as listed in the ECDC 
data sheet were matched to the Global Administrative layer level 3 (municipalities) during map 
construction, with each of the GADM (Database of Global Administrative Areas) level 3 
municipalities matched to the corresponding NUTS level 3 region and assigned the same reported 
case data. The data from the ECDC surveillance Atlas was collected for each week of the transmission 
season, for human and equine cases, and then combined for each region, to generate monthly maps 
of human case reports, and cumulative total maps for human and equine cases. 
2.6. Statistical Analysis 
Non-parametric Mann Whitney U tests were performed in Microsoft Excel (version 16.21.1) to 
compare the number of Cx. pipiens complex mosquitoes for each trap type in a given sampling 
location. 
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3. Results 
3.1. Mosquito Species Abundance and Diversity 
A total of 1062 mosquitoes comprising 840 unfed females, 28 blood-fed females, 9 gravid females 
and 185 males were captured (Table 1). Species belonging to the Cx. pipiens complex were the most 
abundant, comprising 62.5% (n = 664) of the total collection across both RUs. Additional species 
collected included Culiseta (Cs.) longiareolata (16.1%, n = 171), Ae. caspius (11.0%, n = 117), Ae. albopictus 
(7.4%, n = 79) and species belonging to the Anopheles (An.) maculipennis complex (1.8%, n = 19). The 
remaining 1.1% (n = 12) of mosquitoes were not possible to morphologically identify using keys due 
to damage during trapping. Individuals of the Cx. pipiens complex and Cs. longiareolata specimens 
were collected from all sites within both regions. In the RU of Palaio Faliro, Attica region, Ae. 
albopictus specimens were collected in all three sites and single individuals were also collected in Agia 
Triada and Dalamanara within the RU of Argolida. In contrast, Ae. caspius and An. maculipennis 
complex individuals were collected in all three sites within the RU of Argolida, but not from sites 
within the RU of Palaio Faliro. 
Table 1. Total mosquitoes collected from different locations in the Attica and Peloponnese regions of 
Greece using Biogents Sentinel (BG) traps, Encephalitis Vector Survey (EVS) traps and CDC traps. 
Mosquitoes were morphologically identified using keys and females were classified as non-blood-fed 
(no visible blood in abdomen), blood-fed or gravid. 
Region/ 
Regional Unit 
Sampling 
Location  Species/Complex 
Mosquitoes Collected  
Females  
Males Total 
% of 
Total 
Per Site  
Non-blood-fed Blood-fed Gravid  
Attica/Palaio 
Faliro 
Rema 
Pikrodafnis  
Cx. pipiens complex 68 6 3 1 78 55.7 
Ae. albopictus 17 0 0 33 50 35.7 
Cs. longiareolata 1 1 0 7 9 6.4 
Unidentified  3 0 0 0 3 2.1 
Dimarchio  
Cx. pipiens complex 47 1 0 0 48 64.9 
Ae. albopictus 8 0 0 5 13 17.6 
Cs. longiareolata 0 1 0 12 13 17.6 
KAPI 
Cx. pipiens complex 106 2 2 8 118 84.3 
Ae. albopictus 4 1 0 9 14 10.0 
Cs. longiareolata 2 1 0 4 7 5.0 
Unidentified  1 0 0 0 1 0.7 
Peloponnese/ 
Argolida 
Agia Triada  
Cx. pipiens complex 101 2 3 9 115 54.0 
Ae. albopictus 1 0 0 0 1 0.5 
Cs. longiareolata 31 0 0 64 95 44.6 
Ae. caspius 1 0 0 0 1 0.5 
An. maculipennis complex  0 0 0 1 1 0.5 
Nea Tirintha 
Cx. pipiens complex 140 3 0 4 147 49.0 
Cs. longiareolata 14 1 0 23 38 12.7 
Ae. caspius 91 2 0 1 94 31.3 
An. maculipennis complex  13 3 0 0 16 5.3 
Unidentified  5 0 0 0 5 1.7 
Dalamanara  
Cx. pipiens complex 153 4 1 0 158 81.0 
Ae. albopictus 1 0 0 0 1 0.5 
Cs. longiareolata 5 0 0 4 9 4.6 
Ae. caspius 22 0 0 0 22 11.3 
An. maculipennis complex  2 0 0 0 2 1.0 
Unidentified  3 0 0 0 3 1.5 
Total collected  840 28 9 185 1062 – 
3.2. Species Trap Comparison 
In both RUs, BG traps collected both more overall mosquitoes of all species, and a greater 
number of specimens from the Cx. pipiens complex, than CDC traps and EVS traps (Table 2). As the 
data was not normally distributed, non-parametric Mann–Whitney tests were used to determine any 
significant differences in the number of Cx. pipiens complex mosquitoes collected using different trap 
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types (Table 2). In the RU of Palaio Faliro, BG traps collected more Cx. pipiens complex mosquitoes (n 
= 101) than CDC (n = 46) and EVS (n = 41) traps although the comparison between BG and CDC traps 
was not statistically significant (Mann-Whitney U = 258.0, p = 0.07). In the RU of Argolida BG traps 
collected significantly more Cx. pipiens complex (n = 214) than CDC (n = 69) and EVS (n = 50) traps 
(Mann–Whitney U = 40, p = 0.02; U = 32, p = 0.01, respectively). 
Table 2. Mann–Whitney statistical analysis comparing the number of Cx. pipiens complex mosquitoes 
collected using three traps. 
Region/Regional Unit Trap Comparison 1 U-Value Z-Score p-Value 
Attica/Palaio Faliro 
BG vs. CDC 258.0 1.834 0.07 
BG vs EVS 218.5 2.517 0.01 
 
CDC vs. EVS 342.5 0.372 0.71 
Peloponnese/ Argolida 
BG vs. CDC 40.0 2.256 0.02 
BG vs EVS 32.0 2.667 0.01 
CDC vs. EVS 76.5 0.385 0.70 
1 Biogents Sentinel traps (BG traps), Centre for Disease Control miniature light traps (CDC traps) and 
Heavy-Duty Encephalitis Vector Survey traps (EVS traps). 
3.3. Molecular Identification of Species 
Sanger sequencing of CO1 gene fragments [47–49] was undertaken to confirm morphological 
identification of species and to also determine the species of morphologically unidentified specimens 
that had been damaged during trapping. Representative CO1 gene fragment sequences from 
individuals of the Cx. pipiens complex from all six collection sites across both RUs did not produce 
sufficient sequence variation to determine biotypes (Table 3). Sequencing an additional CO1 fragment 
[48] successfully confirmed the identification of Cs. longiareolata (n = 3) and Ae. albopictus (n = 3). 
Sequencing of an alternative CO1 fragment [47] was required to successfully confirm Ae. caspius (n = 
3) due to unsuccessful amplification of other CO1 fragments. Speciation of a larger number of Cx. 
pipiens complex individuals (~40% of individuals from each location using different trapping types) 
was undertaken using multiplex species-specific assays [37,50] to determine the pipiens, molestus and 
hybrid biotypes. Multiplex species-specific assays revealed the presence of both biotypes of Cx. 
pipiens (pipiens type and molestus type) in addition to hybrids (Figure 2). In the RU of Palaio Faliro 
overall 54.5% (n = 79) were confirmed as the pipiens type, 20.0% (n = 29) as the molestus type and 25.5% 
(n = 37) as hybrids. In the RU of Argolida, 68.1% (n = 98) were pipiens type, 8.3% (n = 12) molestus type 
and 23.6% (n = 34) hybrids. 
Table 3. CO1 GenBank accession numbers for representatives of species confirmed by molecular 
identification. The location, species and CO1 gene fragment in addition to the accession number on 
GenBank are shown. 
Specimen 
Code  
Sampling 
Location  
Morphological 
Identification 
CO1 Gene 
Fragment  
(Reference) 
GenBank 
Accession Number 
AT1 Agia Triada Cx. pipiens  [49] MN005042 
RP1 
Rema 
Pikrodafnis Cx. pipiens  [49] MN005043 
DI1  Dimarchio Cx. pipiens  [49] MN005044 
DA1 Dalamanara Cx. pipiens  [49] MN005045 
KA1 Kapi Cx. pipiens  [49] MN005046 
NT1 Nea Tirintha Cx. pipiens  [49] MN005047 
RP2 
Rema 
Pikrodafnis Cs. longiareolata [48] MN005048 
DA2 Dalamanara Cs. longiareolata [48] MN005049 
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AT2 Agia Triada Cs. longiareolata [48] MN005050 
NT2 Nea Tirintha Ae. caspius [47] MN005051 
AT3 Agia Triada Ae. caspius [47] MN005052 
DA3 Dalamanara Ae. caspius [47] MN005053 
DI2 Dimarchio Ae. albopictus [48] MN005054 
AT4 Agia Triada Ae. albopictus [48] MN005055 
RP3 Rema 
Pikrodafnis 
Ae. albopictus [48] MN005056 
 
Figure 2. Prevalence rates of Cx. pipiens biotypes. Multiplex species-specific PCR assays were 
undertaken on Cx. pipiens complex individuals from three sampling locations in (A) the Regional Unit 
(RU) of Palaio Faliro in the Attica region and (B) the RU of Argolida in the Peloponnese region of 
Greece during May–June 2018. 
3.4. WNV Infection Rates in Field Mosquitoes 
A total of 630 individual mosquitoes (229 from RU of Palaio Faliro and 401 from RU of Argolida) 
were screened for the presence of WNV cDNA. This included individual mosquitoes from the Cx. 
pipiens complex (n = 458), Ae. caspius (n = 114), Ae. albopictus (n = 31), An. maculipennis complex (n = 15) 
and unidentified mosquitoes (n = 12). In total, four Cx. pipiens complex individuals were WNV 
positive with no evidence of infection in any of the other species/species complexes. Real-time PCR 
results were confirmed by running PCR products through gel electrophoresis to confirm the correct 
target 144 base pair PCR products (Open Science Framework: DOI 10.17605/OSF.IO/D76QF). These 
positive individuals were unfed females which were molecularly identified as three pipiens biotype 
and one hybrid biotype, all collected from Dalamanara within the RU of Argolida in the Peloponnese 
region. Two WNV-infected mosquitoes were found on consecutive days (30 May 2018, 31 May 2018) 
in two sites (termed private house 1 and private house 2) in Dalamanara. 
3.5. WNV Reported Cases 
The reported human cases of WNV during the 2018 transmission season revealed only two 
human cases in the Peloponnese region all year, and specifically in the area of Argolida just one 
Insects 2020, 11, 329 9 of 16 
 
human case was recorded which occurred in August (Figure 3). In the Attica region, however, a total 
of 159 human cases and 4 equine outbreaks were recorded during the transmission season, with the 
first reported human cases occurring in June. Specifically, there were 11 human cases reported in the 
municipality unit in which Palaio Faliro is located, occurring between August and November. 
 
Figure 3. Reported human and equine cases of West Nile virus (WNV) in the 2018 transmission 
season. Maps were constructed in ArcMap 10.5 (ArcGIS, Esri, Redlands, USA) using Global 
Administrative layers for Greece (level 3), downloaded from www.gadm.org (Version 3.6) and ECDC 
WNV case report data from “Transmission of West Nile virus, June to December 2018 – Table of cases, 
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2018 transmission season” downloaded from www.ecdc.europa.eu. The data from the ECDC 
surveillance Atlas was collected for each week of the transmission season, for human and equine 
cases, and then combined for each region, to generate monthly maps of human case reports, and 
cumulative total maps for human and equine cases. Mosquito sampling locations shown as blue 
circles, with collection locations in the Regional Unit of Argolida in the Peloponnese region to the 
west, and those in the Regional Unit of Palaio Faliro in the Attica region to the east. 
4. Discussion 
Our mosquito trapping experiments using different adult traps show that in both regions BG 
traps collected both a larger number of mosquitoes of all species, and a greater number of individuals 
from the Cx. pipiens complex (although this was not statistically significant in the RU of Palaio Faliro). 
Previous trap comparison studies undertaken in Europe report contrasting results, ranging from BG 
traps in Germany collecting more Cx. pipiens complex mosquitoes than CDC and EVS traps [53], to a 
study in Spain showing no statistically significant differences between BG and CDC traps in 
collecting specimens from this complex [54]. CDC light traps are the most commonly used method 
for the surveillance of mosquito populations and are effective at trapping night-biting species from 
the Culex and Anopheles genera. In contrast, BG and EVS traps can be more effective against day-
biting mosquitoes (using CO2 instead of a light source for attraction), including Ae. albopictus [55]. In 
addition, BG traps can be used with chemical lures that increase their trapping efficiency by imitating 
the olfactory cues of potential hosts. As expected, our results highlight that using a variety of trapping 
types can increase the species diversity of collections. However, a greater number of target vector 
species, such as individuals of the Cx. pipiens complex and invasive Aedes species (e.g., Ae. albopictus) 
could potentially be targeted using BG traps when capacity and resources are limited. 
Although different mosquito species (across multiple genera) have been demonstrated to be 
competent vectors of WNV [6], the major vectors for WNV belong to the Cx. pipiens complex. In this 
study, we collected individuals of the Cx. pipiens complex in addition to other species including Ae. 
albopictus, Cs. longiareolata and Ae. caspius shown previously to be present in Greece [56–58]. The 
presence of the pipiens biotype, molestus biotype and hybrids in both the Attica and Peloponnese 
regions is consistent with previous studies in Greece [22,49,50]. We found variation in the prevalence 
of the different biotypes with the pipiens biotype comprising 54.5% (n = 79) in the RU of Palaio Faliro, 
20.0% (n = 20) molestus biotype and 25.5% (n = 37) of hybrids. These results differ from another study 
that had found a more homogeneous molestus biotype population [44] which could be due to 
seasonality of collections as this study collected later into the transmission season (August–
September 2010). In the RU of Argolida the biotypes of the Cx. pipiens complex were 68.1% (n = 98) of 
pipiens biotype, 8.3% (n = 12) of molestus biotype and 23.6% (n = 34) of molestus and pipiens hybrids. 
The high percentage of hybrids in this RU is similar to a previous study conducted in the area after 
the 2017 outbreak which reported 37% hybrids, 41% pipiens and 22% molestus biotypes [59]. 
In the USA, the high number of WNV cases in humans was correlated to the high number of 
hybrids [60]. Europe is considered to have more “pure” types but hybridization can result in a 
catholic feeding behaviour (feeding both on birds and mammals) increasing the risk of mixed 
populations acting as bridge-vectors of WNV between birds and humans/equines [44]. The feeding 
patterns of the different mosquito species, and the different biotypes within the species complex, are 
important in order to identify the contribution of each vector to both the enzootic maintenance of 
WNV in avian hosts, and the spill-over transmission to humans and horses [61]. In northern Greece, 
the predominance of the pipiens biotype could be facilitating the maintenance of the enzootic cycle of 
the virus between mosquitoes and birds in the area [44]. The presence of the molestus biotype and the 
existence of hybrids can promote an opportunistic biting behaviour that could contribute to the spill-
over of infection to humans and equines. 
In our study, we also collected several other species that have been implicated or shown to be 
potential WNV vectors. Experimental transmission has been shown for both Cs. longiareolata and Ae. 
albopictus [1] whereas laboratory experiments indicated that Ae. caspius may be incapable of 
transmitting WNV [33,62]. However, in some countries the high densities and detection of WNV in 
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wild-caught specimens, have suggested this species may have a potential role in transmission, 
particularly during an outbreak when the level of viral circulation is high [63]. The presence of Ae. 
albopictus, an invasive species that has expanded its range across Europe since the late 1970s, would 
suggest the potential for transmission of additional arboviruses. Aedes albopictus has the ability to 
adapt to colder temperatures and stay dormant during the winter, and has previously been shown 
to be responsible for chikungunya virus outbreaks in Italy in 2007 [64]. In Greece, since its first 
reported presence in 2003 in the western part of the country, this species has now spread to almost 
every district [57]. Aedes albopictus has also been the principle vector responsible for dengue virus 
outbreaks in Hawaii in 2001–2002 and Mauritius in 2009 [65,66] and is a potential vector of Zika virus 
[67,68]. Dengue virus was detected in Ae. albopictus in Spain in 2015 [69] highlighting the potential 
for this species to contribute to transmission in Europe. Furthermore, it can be a competent vector of 
WNV when experimentally tested in laboratory conditions [70] although it has never been recorded 
as a WNV vector in the field, possibly due to its low propensity to bite birds [58]. 
Detection of WNV cDNA in four unfed Cx. pipiens complex specimens would indicate 
circulation of WNV in the RU of Argolida during our collection period in May. This represents the 
minimum number of positive individuals given the possibility of low virus levels being beyond the 
sensitivity (detection limit) of this PCR assay. This is interesting when compared to the spatial and 
temporal records of human and equine cases during 2018 (Figure 3) as only one human case was 
recorded from this area of the Peloponnese region all year, and not until August, suggesting WNV 
may have been circulating in the area for months before resulting in a case of human clinical disease. 
Interestingly, no equine cases were reported in this area for the 2018 transmission season despite 
WNV-infected mosquitoes collected from private houses in Dalamanara in close proximity to a third 
site containing horses (Table S1). The level of urbanization is likely a factor given the molestus biotype 
is considered more anthropophilic and present in urban areas compared to the more ornithophilic 
pipiens biotype more often found in rural areas. The confirmation that three of the positives were 
pipiens biotype, supports the possibility of virus circulating in an enzootic cycle, between birds and 
mosquitoes. However, the presence of WNV in one of the hybrids also demonstrates the potential for 
spill-over transmission to humans and equines in the area at this early time in the season. In 
comparison, no WNV was detected in mosquitoes collected from the RU of Palaio Faliro, but this area 
subsequently recorded a far greater number of human and equine cases during 2018. Across the 
whole Attica region, a total of 159 human cases were recorded, with the first reported cases occurring 
in June, and in the area in which Palaio Faliro is located, 11 human cases were reported, occurring 
between August and November. This highlights the likely variations in spatial and temporal 
transmission dynamics between these two very different localities, and the variable factors that can 
influence risk of host infection and subsequent disease during the transmission season. 
5. Conclusions 
Sampling during the onset of the 2018 WNV at pre-disease stage in the RUs in the Attica and 
Peloponnese regions was particularly important in a year in which more than 300 human cases were 
recorded in Greece. These results, combined with previous entomological surveys conducted in 
Greece, show the high occurrence of hybrids between the pipiens and molestus biotypes of Cx. pipiens. 
Previous studies have demonstrated the importance of hybrids as bridge vectors of WNV. Their role 
in spill-over transmission to humans, and the presence of hybrids (and WNV infections) in RUs in 
the Attica and Peloponnese regions of Greece suggest these areas are vulnerable to outbreaks. 
Furthermore, 2018 was the first year in Greece in which WNV human cases were recorded so early 
in the transmission period with six human cases confirmed by late June. Future entomological 
surveillance studies should incorporate molecular xenomonitoring to determine this potential 
expansion of the transmission season to provide early warning systems for potential WNV outbreaks. 
Notification of human WNV cases in Europe through The European Surveillance System (TESSy) 
[71] of the ECDC allows weekly mapping of human cases [27]. In addition, reporting of WNV 
encephalomyelitis in horses to the European Commission is carried out via the Animal Disease 
Notification System (ADNS). As reported cases of WNV infection in humans have been from 
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southern and central European countries and a majority of human infections are asymptomatic, it is 
particularly important to undertake entomological and avian surveillance to determine if WNV 
circulation is occurring in a particular area, as a precursor to potential spill-over transmission to 
humans and other mammals. In particular, entomological surveys to determine the distribution of 
mosquito vectors such as Cx. pipiens through the Pan-European VectorNet [72] will play a crucial role 
in an integrated approach to WNV surveillance and control efforts to minimise the impact of 
outbreaks on veterinary and public health. 
Supplementary Materials: The following are available online at www.mdpi.com/2075-4450/11/6/329/s1, Table 
S1: Geographical locations with GPS co-ordinates of mosquito trapping sites within the Attica and Peloponnese 
regions of Greece.  
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